305 related articles for article (PubMed ID: 24610337)
1. Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndrome.
Lingman Framme J; Borte S; von Döbeln U; Hammarström L; Oskarsdóttir S
J Clin Immunol; 2014 May; 34(4):514-9. PubMed ID: 24610337
[TBL] [Abstract][Full Text] [Related]
2. The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome.
Froňková E; Klocperk A; Svatoň M; Nováková M; Kotrová M; Kayserová J; Kalina T; Keslová P; Votava F; Vinohradská H; Freiberger T; Mejstříková E; Trka J; Sedivá A
PLoS One; 2014; 9(12):e114514. PubMed ID: 25485546
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.
Somech R; Lev A; Simon AJ; Korn D; Garty BZ; Amariglio N; Rechavi G; Almashanu S; Zlotogora J; Etzioni A
Isr Med Assoc J; 2013 Aug; 15(8):404-9. PubMed ID: 24079059
[TBL] [Abstract][Full Text] [Related]
4. Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.
Barbaro M; Ohlsson A; Borte S; Jonsson S; Zetterström RH; King J; Winiarski J; von Döbeln U; Hammarström L
J Clin Immunol; 2017 Jan; 37(1):51-60. PubMed ID: 27873105
[TBL] [Abstract][Full Text] [Related]
5. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls.
Şentürk G; Ng YY; Eltan SB; Başer D; Ogulur I; Altındirek D; Fırtına S; Yılmaz H; Kocamış B; Kıykım A; Camcıoğlu Y; Ar MC; Sudutan T; Beken S; Temel ŞG; Alanay Y; Karakoc-Aydiner E; Barış S; Özen A; Özbek U; Sayitoğlu M; Hatırnaz Ng Ö
Scand J Immunol; 2022 Mar; 95(3):e13130. PubMed ID: 34951041
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-Up of Newborns with 22q11 Deletion Syndrome and Low TRECs.
Framme JL; Lundqvist C; Lundell AC; van Schouwenburg PA; Lemarquis AL; Thörn K; Lindgren S; Gudmundsdottir J; Lundberg V; Degerman S; Zetterström RH; Borte S; Hammarström L; Telemo E; Hultdin M; van der Burg M; Fasth A; Oskarsdóttir S; Ekwall O
J Clin Immunol; 2022 Apr; 42(3):618-633. PubMed ID: 35080750
[TBL] [Abstract][Full Text] [Related]
7. Cellular calibrators to quantitate T-cell receptor excision circles (TRECs) in clinical samples.
Punwani D; Gonzalez-Espinosa D; Comeau AM; Dutra A; Pak E; Puck J
Mol Genet Metab; 2012 Nov; 107(3):586-91. PubMed ID: 23062576
[TBL] [Abstract][Full Text] [Related]
8. Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns.
Marakhonov AV; Efimova IY; Mukhina AA; Zinchenko RA; Balinova NV; Rodina Y; Pershin D; Ryzhkova OP; Orlova AA; Zabnenkova VV; Cherevatova TB; Beskorovainaya TS; Shchagina OA; Polyakov AV; Markova ZG; Minzhenkova ME; Shilova NV; Larin SS; Khadzhieva MB; Dudina ES; Kalinina EV; Mudaeva DA; Saydaeva DH; Matulevich SA; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Nurgalieva LR; Saifullina EV; Belyaeva TI; Romanova OS; Voronin SV; Shcherbina A; Kutsev SI
J Clin Immunol; 2024 Apr; 44(4):93. PubMed ID: 38578360
[TBL] [Abstract][Full Text] [Related]
9. Establishing Simultaneous T Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) Quantification Assays and Laboratory Reference Intervals in Healthy Individuals of Different Age Groups in Hong Kong.
Kwok JSY; Cheung SKF; Ho JCY; Tang IWH; Chu PWK; Leung EYS; Lee PPW; Cheuk DKL; Lee V; Ip P; Lau YL
Front Immunol; 2020; 11():1411. PubMed ID: 32765500
[TBL] [Abstract][Full Text] [Related]
10. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
Front Immunol; 2020; 11():1948. PubMed ID: 33178177
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.
Kwan A; Church JA; Cowan MJ; Agarwal R; Kapoor N; Kohn DB; Lewis DB; McGhee SA; Moore TB; Stiehm ER; Porteus M; Aznar CP; Currier R; Lorey F; Puck JM
J Allergy Clin Immunol; 2013 Jul; 132(1):140-50. PubMed ID: 23810098
[TBL] [Abstract][Full Text] [Related]
12. TREC and KREC profiling as a representative of thymus and bone marrow output in patients with various inborn errors of immunity.
Dasouki M; Jabr A; AlDakheel G; Elbadaoui F; Alazami AM; Al-Saud B; Arnaout R; Aldhekri H; Alotaibi I; Al-Mousa H; Hawwari A
Clin Exp Immunol; 2020 Oct; 202(1):60-71. PubMed ID: 32691468
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.
Boyarchuk O; Yarema N; Kravets V; Shulhai O; Shymanska I; Chornomydz I; Hariyan T; Volianska L; Kinash M; Makukh H
Front Immunol; 2022; 13():999664. PubMed ID: 36189201
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for severe T and B cell lymphopenia identifies a fraction of patients with Wiskott-Aldrich syndrome.
Borte S; Fasth A; von Döbeln U; Winiarski J; Hammarström L
Clin Immunol; 2014 Nov; 155(1):74-78. PubMed ID: 25217881
[TBL] [Abstract][Full Text] [Related]
15. TREC/KREC Newborn Screening followed by Next-Generation Sequencing for Severe Combined Immunodeficiency in Japan.
Wakamatsu M; Kojima D; Muramatsu H; Okuno Y; Kataoka S; Nakamura F; Sakai Y; Tsuge I; Ito T; Ueda K; Saito A; Morihana E; Ito Y; Ohashi N; Tanaka M; Tanaka T; Kojima S; Nakajima Y; Ito T; Takahashi Y
J Clin Immunol; 2022 Nov; 42(8):1696-1707. PubMed ID: 35902420
[TBL] [Abstract][Full Text] [Related]
16. [Newborn screening for severe T and B lymphocyte deficiencies in Switzerland].
Fouriki A; Schnider C; Theodoropoulou K; Pachlopnik J; Hofer M; Candotti F
Rev Med Suisse; 2021 Jan; 17(720-1):68-76. PubMed ID: 33443835
[TBL] [Abstract][Full Text] [Related]
17. Detecting 22q11.2 Deletion Syndrome in Newborns with Low T Cell Receptor Excision Circles from Severe Combined Immunodeficiency Screening.
Liao HC; Liao CH; Kao SM; Chiang CC; Chen YJ
J Pediatr; 2019 Jan; 204():219-224.e1. PubMed ID: 30268402
[TBL] [Abstract][Full Text] [Related]
18. Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review.
Shinwari K; Bolkov M; Tuzankina IA; Chereshnev VA
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(2):132-149. PubMed ID: 32748762
[TBL] [Abstract][Full Text] [Related]
19. Determining Laboratory Reference Values of TREC and KREC in Different Age Groups of Iranian Healthy Individuals.
Shakerian L; Pourpak Z; Shamlou S; Domsgen E; Kazemnejad A; Dalili H; Nourizadeh M
Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):143-152. PubMed ID: 31066250
[TBL] [Abstract][Full Text] [Related]
20. TREC and KREC in very preterm infants: reference values and effects of maternal and neonatal factors.
Remaschi G; Ricci S; Cortimiglia M; De Vitis E; Iannuzzi L; Boni L; Azzari C; Dani C
J Matern Fetal Neonatal Med; 2021 Dec; 34(23):3946-3951. PubMed ID: 31885296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
